Piper Sandler Maintains Overweight on IBEX, Lowers Price Target to $24
Portfolio Pulse from richadhand@benzinga.com
Piper Sandler analyst Arvind Ramnani maintains an Overweight rating on IBEX (NASDAQ:IBEX) but lowers the price target from $32 to $24.
May 19, 2023 | 8:12 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Piper Sandler analyst Arvind Ramnani maintains an Overweight rating on IBEX, but lowers the price target from $32 to $24.
The news of Piper Sandler maintaining an Overweight rating on IBEX indicates a positive outlook for the stock. However, the lowering of the price target from $32 to $24 may create uncertainty among investors, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100